The August issue of Pain Medicine includes several peer-reviewed articles focusing on vertebrogenic pain – defining patient, clinical, and imaging factors associated with basivertebral nerve (BVN) ablation treatment success following the Intracept Procedure; and a...
Published guidelines with highest evidence rating provide physicians confidence to adopt basivertebral nerve ablation as first-line treatment MINNEAPOLIS – September 20, 2022 – Relievant Medsystems, a company focused on transforming the diagnosis and treatment of...
Relievant Medsystems shared today that the company’s breakthrough chronic low back pain treatment, the Intracept Procedure, was featured on NBC’s TODAY this morning. The full segment can be viewed here. “This is an exciting story, not only for the patients I’ve...
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today that new Category I Current Procedural Terminology (CPT) codes for the Intracept Procedure are in effect as of January 1, 2022....
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month results from a Level 1, prospective, randomized, multi-center trial (INTRACEPT) that further validate the safety,...
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth Revision,...
